EcoDrugPlus

Monoglyceride Lipase

Ensembl ID : ENSONIG00000037558
Gene Symbol: MGLL
1 Cross references
208 Possible Orthologues:

Motilin Receptor

Ensembl ID : ENSONIG00000005699
Gene Symbol: MLNR
1 Cross references
174 Possible Orthologues:

Mucosal Pentraxin

Ensembl ID : ENSONIG00000005955
Gene Symbol: LOC100701841
2 Cross references
408 Possible Orthologues:

Muscarinic Receptor 2 Subtype

Ensembl ID : ENSONIG00000020697
Gene Symbol: LOC100534441
4 Cross references
195 Possible Orthologues:

Natriuretic Peptide Receptor 1

Ensembl ID : ENSONIG00000007561
Gene Symbol: NPR1
4 Cross references
190 Possible Orthologues:

Natriuretic Peptide Receptor 2

Ensembl ID : ENSONIG00000001521
Gene Symbol: NPR2
1 Cross references
191 Possible Orthologues:

Natriuretic Peptide Receptor 3

Ensembl ID : ENSONIG00000013952
Gene Symbol: NPR3
4 Cross references
211 Possible Orthologues:

Neurogenic Locus Notch Homolog Protein 1

Ensembl ID : ENSONIG00000007454
Gene Symbol: LOC100703553
3 Cross references
196 Possible Orthologues:

Neurogenic Locus Notch Homolog Protein 2

Ensembl ID : ENSONIG00000001645
Gene Symbol: LOC100696073
3 Cross references
197 Possible Orthologues:

Neuromedin-K Receptor-Like

Ensembl ID : ENSONIG00000037964
Gene Symbol: TACR3B
2 Cross references
218 Possible Orthologues:

Neuromedin-K Receptor-Like

Ensembl ID : ENSONIG00000039363
Gene Symbol: TACR3A
3 Cross references
208 Possible Orthologues:

Neuronal Acetylcholine Receptor Subunit Alpha-7

Ensembl ID : ENSONIG00000005698
Gene Symbol: LOC100691116
4 Cross references
205 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).